Recent Rectal Cancer News

Managing Side Effects From EGFR Inhibitors

(April 10, 2018)

CancerConnect News: Epidermal Growth Factor Receptor (EGFR) inhibitor drugs are a type of precision cancer medicine commonly used to treat lung, colon, head and neck and other cancers that over express... Continue Reading


Targeting both BRAF and EGFR doubles progression-free survival in metastatic colorectal cancer

(October 16, 2017)

Recent successes in genetically targeted precision cancer medicines are improving outcomes in a number of cancers.  Ensuring patients undergo genomic sequencing to determine if they have treatable targets... Continue Reading


NSAIDs Decrease Risk of Colorectal Cancer

(September 18, 2017)

Nonsteroidal anti-inflammatory drugs (NSAIDS) are medicines that are used for the treatment of a wide range of musculoskeletal illnesses including spinal disorders, osteoarthritis and inflammatory conditions... Continue Reading